DFAN14A: Definitive additional proxy soliciting ma
Post# of 147721
https://d1io3yog0oux5.cloudfront.net/sec/0001...088338.pdf
GROUP OF CYTODYN STOCKHOLDERS NOMINATES FIVE HIGHLY QUALIFIED DIRECTOR CANDIDATES TO REPLACE BOARD RESPONSIBLE FOR MISMANAGEMENT AND VALUE DESTRUCTION
Nominees:
Thomas Errico, MD
Bruce K. Patterson, MD
Paul A. Rosenbaum
Peter Staats, MD
Melissa A. Yaeger, JD